Cyxone AB
CYXO
Overview
Corporate Details
- ISIN(s):
- SE0007815428 (+2 more)
- LEI:
- 54930034OH16ROAY4K87
- Country:
- Sweden
- Address:
- Hyllie Boulevard 34, 215 32 Malmö
- Website:
- https://cyxone.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Cyxone AB develops disease-modifying therapies for autoimmune diseases.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-28 | Carl Magnus Högerkorp | Other | Buy | 64,950 | 40,788.60 SEK |
| 2023-06-27 | Carl Magnus Högerkorp | Other | Buy | 6,050 | 3,690.50 SEK |
| 2023-03-03 | Carl Magnus Högerkorp | Other | Buy | 100,010 | 51,005.10 SEK |
| 2023-03-02 | Carl Magnus Högerkorp | Other | Buy | 10,873 | 5,653.96 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | 7,763,096.88 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | N/A |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | 7,790,163.03 SEK |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | N/A |
| 2021-07-12 | Mikeoo Holding AB | Other | Other | 1,788,732 | 7,441,125.12 SEK |
| 2021-07-12 | Mikael Lindstam | Other | Other | 1,788,732 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
SenzaGen AB | Sweden | SENZA | |
|
SoftOx Solutions AS | Norway | SOFTX | |
|
Spago Nanomedical AB | Sweden | SPAGO | |
/other/Spermosens_AB_publ-logo.jpg?Expires=1750114632&Signature=GSi7JmhzpohsWqmX5QUlXzhJ3ViPz3qfhKF5M57QgtH68XDGl6kGsefcvHlKMf6rAAnSTilIwSWRcfrELERgQndGzjzFdLJ5kktAbpMnbl~NiycYtnLKpTUgkRdFYPv1ngNjxuXW-uRf73uMkkx3yvlPfxTus4K8bOSrfbLSho4YnK7gheJUvL6mPDBZzGoYrA2eKpyKxYVzgp6LNEAcljzjgZBCq2sjBbuth2bQfNNxUH7yEMx~T0KPDKAFp2ffTNmkoTz6EUrkBKXDPmV2QcBfTrhR-JZ-ZdFbWkQm6ISf25EYmHB50716hFy1IC7CSglhbw4uW~V41J7OsNx~hQ__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Spermosens AB (publ) | Sweden | SPERM | |
|
Spexis AG | Switzerland | SPEX | |
|
Sprint Bioscience | Sweden | SPRINT | |
|
Stayble Therapeutics AB | Sweden | STABL | |
|
Stem Cells Spin Spolka Akcyjna | Poland | SCS | |
|
Strategic Partners A/S | Denmark | STRAP | |
|
STRIX GROUP PLC | Isle of Man | KETL |